Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEBIVOLOL vs NECITUMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NEBIVOLOL vs NECITUMUMAB: Safety Overview

Metric NEBIVOLOL NECITUMUMAB
Total FAERS Reports 6,308 367
Deaths Reported 455 69
Death Rate 7.2% 18.8%
Hospitalizations 2,586 131
Average Patient Age 66.1 yrs 65.4 yrs
% Female Patients 57.5% 20.0%
FDA Approval Date Apr 16, 2015 N/A
Manufacturer Apnar Pharma LP Eli Lilly and Company
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription